Close

OraSure Technologies (OSUR) Updates on Significant OraQuick Ebola Rapid Antigen Test Progress

September 29, 2015 8:09 AM EDT Send to a Friend
OraSure Technologies (NASDAQ: OSUR) announced that it has made significant progress regarding the commercialization of its OraQuick Ebola Rapid Antigen ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login